About Aliada Therapeutics
Aliada Therapeutics is a company based in Boston (United States) founded in 2021 was acquired by AbbVie in October 2024. Aliada Therapeutics has raised $33 million across 1 funding round from investors including AbbVie, RA Capital and Johnson & Johnson Innovation – JJDC. Aliada Therapeutics operates in a competitive market with competitors including WuXi AppTec, Eurofins Scientific, Ipsen, ANI Pharmaceuticals and Red Nucleus, among others.
- Headquarter Boston, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Aliada Therapeutics
Unlock access to complete
Unlock access to complete
Funding Insights of Aliada Therapeutics
Aliada Therapeutics has successfully raised a total of $33M through 1 strategic funding round. The most recent funding activity was a Seed round of $33 million completed in July 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Aliada Therapeutics
Aliada Therapeutics has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include AbbVie, RA Capital and Johnson & Johnson Innovation – JJDC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm backed by Johnson & Johnson
|
Locked | Locked | Locked | |
|
RA Capital is engaged in evidence-based investing in healthcare and life sciences.
|
Locked | Locked | Locked | |
|
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
Locked | Locked | Locked |
Investor details for Aliada Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aliada Therapeutics
Investment portfolio details for Aliada Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Aliada Therapeutics
Detailed financials for Aliada Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aliada Therapeutics Comparisons
Peer comparison for Aliada Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aliada Therapeutics
Aliada Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as WuXi AppTec, Eurofins Scientific, Ipsen, ANI Pharmaceuticals and Red Nucleus, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of CRO and CDMO services
|
|
| Locked | Locked | Locked |
Laboratory testing and contract research services are provided globally.
|
|
| Locked | Locked | Locked |
Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes
|
|
| Locked | Locked | Locked |
Branded and generic prescription drugs are developed, manufactured, and marketed.
|
|
| Locked | Locked | Locked |
Advisory, scientific, and medical communications provided for pharmaceutical industry.
|
|
| Locked | Locked | Locked |
Regulatory support, brand differentiation, and prototyping services are provided.
|
Detailed competitors of Aliada Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aliada Therapeutics
Complete news archive for Aliada Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aliada Therapeutics
Aliada Therapeutics was founded in 2021.
Aliada Therapeutics is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Aliada Therapeutics is a funded company, having raised a total of $33M across 1 funding round to date.
Aliada Therapeutics, backed by 33000000.0 from Johnson Johnson Innovation JJDC, RA Capital Management, focuses on providing healthcare solutions, biopharma outsourcing, and diversified. Provider of drug research development services for multiple therapeutic areas. Driving innovation, growth, and excellence in its industry sectors.
Aliada Therapeutics's top competitors include WuXi AppTec, ANI Pharmaceuticals and Aptar.
Aliada Therapeutics has 3 investors. Key investors include AbbVie, RA Capital, and Johnson & Johnson Innovation – JJDC.